Stay updated on IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The header now displays Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:36:16.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added. The previous notices about government funding and Revision: v3.4.1 have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T14:34:44.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and NIH Clinical Center operations with links for updates. The page revision was updated to v3.4.1, replacing v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T10:40:59.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Minor UI text changes and label updates on the study page, including Show glossary, capitalization adjustments for 'Last Update Submitted that Met QC Criteria', and footer notes such as No FEAR Act Data and Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T06:20:52.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Site revision updated from v3.3.3 to v3.3.4, with no changes to the study details, eligibility criteria, or trial data. This appears to be a technical update to the site interface. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:15:25.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:13:36.000Z thumbnail image

Stay in the know with updates to IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page.